Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Device Recalls / Accriva Diagnostics, INC.

QualityClass II recall11 Nov 2026

Accriva Diagnostics, INC.

11 Nov 2026: Class II recall · Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103. Recorded in the openFDA device enforcement reports.

View the source record

Reported
11 Nov 2026
Recall Class
Class II
Product
Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103
Reason
Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overesti
Country
United States
Status
Ongoing
Reference
Z-0317-2027
Location
San Diego, CA
What this signal means

A recall puts quality, regulatory, field service and communications under pressure at once.

  1. Class II leads with 660 of 741, then Class I (68).
  2. 235 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Accriva Diagnostics, INC.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.

Start free

More in Class II

Device Recalls

See all

Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.